Necessary diagnostic components include CD4-count testing (ideally at point-of-care) and lateral flow assays for cryptococcal antigen (CrAg) and TB lipoarabinomannan (TB-LAM) screening [3]. This evidence concerns the gene AGAP3 and tuberculosis.